Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of the Neurological Sciences|June 28, 2023
Recurrence of intracranial artery dissection more than a half year after the initial eventNaoki Makita, Ryotaro Ishii, Yoshitaka Yamaguchi, et al.
Neurology and Therapy|August 18, 2025
Differences in Patient-Physician Satisfaction for Migraine Treatment Medications in Patients with and without Medication-Overuse Headache: A Cross-Sectional Real-World SurveyRyotaro Ishii, Takahiro Kitano, Masahiro Iijima, et al.
BMC Neurology|November 20, 2016
Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reportsHisashi Takahashi, Yu-Ichi Noto, Naoki Makita, et al.
Plos One|April 11, 2017
Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's diseaseTakashi Kasai, Masaki Kondo, Ryotaro Ishii, et al.
Plos One|December 1, 2017
Increased levels of plasma total tau in adult Down syndromeTakashi Kasai, Harutsugu Tatebe, Masaki Kondo, et al.
International Journal of Clinical Oncology|February 20, 2026
Nationwide trends in mediastinal tumor and myasthenia gravis surgery in Japan: a decade claims-based analysis (2014-2023)Masamitsu Kido, Satoru Okada, Tatsuo Furuya, et al.
Journal of Alzheimer'S Disease : JAD|May 3, 2014
Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practiceMasaaki Waragai, Saori Hata, Toshiharu Suzuki, et al.
Headache|June 3, 2021
Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequencyRyotaro Ishii, Todd J Schwedt, Gina Dumkrieger, et al.
Scientific Reports|July 5, 2016
Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosisKazuma Murakami, Maki Tokuda, Takashi Suzuki, et al.
Journal of Biochemistry|March 13, 2016
Subgroup differences in 'brain-type' transferrin and α-synuclein in Parkinson's disease and multiple system atrophyAkioh Yoshihara, Masahiko Fukatsu, Kyoka Hoshi, et al.
Pageof 5